A Win For Gain Therapeutics, Inc.
Tue, Feb 24, 2026 at 07:31 PM
Gain Therapeutics, Inc. (GANX:NASDAQ) rocketted at $2.74, representing a gain of 31.1%. On Tue, Feb 24, 2026, GANX:NASDAQ hit a New 2-Week High of $2.74. The stock got featured on our News Catalysts scanner on Thu, Feb 19, 2026 at 08:53 AM in the 'MISCELLANEOUS' category. From Tue, Feb 10, 2026, the stock recorded 66.67% Up Days and 60.00% Green Days
The stock spiked on Thu, Dec 11, 2025 at $4.34 with a volume of 1M+.
About Gain Therapeutics, Inc. (GANX:NASDAQ)
Gain Therapeutics Inc is a development-stage biotechnology company developing novel therapeutics to treat diseases caused by protein misfolding, with an initial focus on lysosomal storage disorders...
Top 10 Gainers:
- Edesa Biotech, Inc. (EDSA:NASDAQ), 67.96%
- Rich Sparkle Holdings Limited (ANPA:NASDAQ), 52.93%
- Brand Engagement Network, Inc. (BNAI:NASDAQ), 40.23%
- Clarivate Plc (CLVT:NYSE), 39.88%
- Ten-League International Holdings Limited (TLIH:NASDAQ), 37.74%
- Palvella Therapeutics, Inc. (PVLA:NASDAQ), 37.08%
- Founder Group Limited (FGL:NASDAQ), 34.26%
- Larimar Therapeutics, Inc. (LRMR:NASDAQ), 31.32%
- Gain Therapeutics, Inc. (GANX:NASDAQ), 31.1%
- Global Interactive Technologies, Inc. (GITS:NASDAQ), 30.9%